Aripiprazole-induced movement disorder [4]

American Journal of Psychiatry

Volumn 163, Issue 1, 2006, Pages 160-161

  Zacher, Jennifer L ^a   Hatchett, A Daniel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; BENZATROPINE; LAMOTRIGINE; VENLAFAXINE; ZIPRASIDONE;

ADULT; BIPOLAR DISORDER; CASE REPORT; DRUG DOSE REDUCTION; FEMALE; GAIT DISORDER; HUMAN; LETTER; MANIA; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MUSCLE STIFFNESS; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; PIPERAZINES; QUINOLONES; SYNDROME;

EID: 30044449291     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.1.160-a     Document Type: Letter

References (5)

1. Gupta S, Masand P: Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry 2004; 16:155-166
2. Duggal HS: Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry 2003; 48:771-772
3. Sachetti E, Valsecchi P: Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first generation antipsychotics: a 124-week case report. Int Clin Psychopharmacol 2003; 18:357-359
4. Sajbel TA, Cheney EM, DeQuardo JR: Aripiprazole-associated dyskinesia. Ann Pharmacother 2005; 39:200-201
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245